Purpose of Induced Pluripotent Stem Cell (iPSC) Marketing Analysis
An important area to consider for purposes of quantifying and assessing conditions within the iPSC market is marketing costs.
Because Google now controls over 70% of online searches, Google Adwords is the single best resource available for analyzing both marketing costs and online search behavior within the induced pluripotent stem cell (iPSC) market. Specifically, this post considers marketing costs for search terms related to iPSCs, using the Google Adwords tool.
Continue reading Marketing Analysis: Price-per-Click Costs Reveal Current Levels of Market Competition for iPSCs
Since iPSCs were first produced in 2006 from mouse cells and in 2007 from human cells, research scientists have recognized the wide-ranging potential of the cell type, including the possibility of using them in drug and toxicology screening, disease modeling, and cellular therapy applications ranging from gene correction, to whole tissue regeneration, individualized medicine, and more.
Since the discovery of induced pluripotent stem cells, the commercial sector has also recognized the huge profits that could potentially be generated from the cell type, and the question being explored among the private sector has been how to generate maximal commercial value through the development of iPSC applications and technologies.
Continue reading Awards Given to Induced Pluripotent Stem Cell (iPSC) Researchers
A SWOT analysis is a well-established method of evaluating strengths, weaknesses, opportunities, and threats within an industry. Claim this exclusive SWOT analysis to get informed about cord blood industry conditions worldwide, including new trends that will affect your business in 2015-16.
Continue reading Cord Blood Industry SWOT Analysis: Strengths, Weaknesses, Opportunities, Threats
Recently released, the “Complete 2015-16 Global Cord Blood Banking Industry Report” discusses new clinical trial market data supporting applications for hematopoietic stem cells (HSCs) from cord blood and mesenchymal stem cells (MSCs) from cord tissue. Within this rapidly evolving ecosystem, those who choose to commit to understanding current opportunities and threats will be positioned for a substantial strategic advantage, says this research available at http://www.bioinformant.com/product/complete-2015-16-global-cord-blood-banking-industry-report/.
Continue reading Cord Blood Banking Industry 2015-16 Global Market Research Report
In the past twelve months, the global regenerative medicine industry has started to attract the attention of investors, as new and promising clinical data results get released. The momentum has been growing in recent years, enabling the cell therapy and genome editing sectors to evolve into a global industry.
Continue reading Epic Year for Regenerative Medicine Investments: Money Speaks Louder than Words
Strategy of the Day: How to Efficiently Convert Cord Blood Banking Leads to Clients
For cord blood banks that are marketing to expectant parents, the time window during which to convert a lead to a client is only nine months at best, often shorter, if an expectant couple does not contact you immediately after becoming aware of the pregnancy.
Under these circumstances, what is the best way to follow-up with your potential clients? Continue reading The One Method for Contacting Cord Blood Leads that Gets 90% Interaction within 3 Minutes
The mesenchymal stem cell industry is well-known for its shifting dynamics, including new alliances, new research advances and innovations. Every month there are major new events that affect market participants.
While it may be possible to stay informed about mesenchymal stem cell industry news in your region, it can be more difficult to track changes on a global scale. For that reason, the following is a summary of significant mesenchymal stem cell industry events for July 2015.
Continue reading Mesenchymal Stem Cell Industry News Round Up | July 2015
In a recent post, we considered commercial entities supporting the development of induced pluripotent stem cell (iPSC) therapies. It is also important to consider the government and academic entities driving forward therapeutic progress with the cell type.
The primary non-commercial institutions working toward this goal are:
- RIKEN Center in Kobe, Japan
- Kyoto University in Kyoto, Japan
- California Institute for Regenerative Medicine (CIRM) in California, USA
Each of these important institutions and their contributions to the development of new iPSC therapies is explored in detail below.
Continue reading Non-Commercial Organizations Supporting the Development of iPSC Therapies
To have a thorough understanding of commercial opportunities within the induced pluripotent stem cell (iPSC) marketplace, it is important to consider commercial entities supporting the development of iPSC therapies. Therefore, this post is dedicated to this important topic.
Continue reading 5 Market Leaders in iPSC Therapy Development You Need to Know
5 More Cord Blood Banking Awareness Stats You May Not Know
In honor of July being National Cord Blood Awareness Month, BioInformant is releasing five more cord blood banking awareness statistics that you may not know. These facts are distributed weekly (every Wednesday) on our social media platforms, as part of our ongoing partnership with the Save the Cord Foundation, a non-profit dedicated to educating the public about the value of cord blood and tissue preservation.
In tackling an educational campaign to promote cord blood banking awareness, it is critical to acknowledge that the effort has two components:
1) Increasing awareness among parents, as well as those who support them, including brothers, sisters, grandparents, and friends.
2) Increasing awareness among the medical community, most notably among obstetricians.
For this reason, our weekly cord blood banking awareness statistics focus on both of these areas. Enjoy these five new facts and join our mailing list below to receive new weekly facts as they are released! Continue reading July is National Cord Blood Awareness Month
Futuristic, the adjective, means “having or involving very modern technology or design.” In no other area has this term become more important than in the area of market research methodologies. Indeed, 2015 has never seen more opportunity for analysis of data, as the total global amount of data is now estimated at approximately 4 zettabytes, with a zettabyte being 10007 bytes.
As such, techniques for managing analysis of this massive global population of data must dynamically evolve as well.
Under these circumstances, it is important to ask yourself, has your market research provider embraced techniques that allow for accurate assessment of this vast population of data? While you may not understand the precise meaning of research terms such as meta-analysis, algorithmic analysis, or predictive trend analysis, there is an easy two-part process that you can use to answer this question, as explained below.
The first element is to consider the transparency of your market research provider with regard to the methodologies that they employ. Without this information, you have no baseline on which to base your conclusions.
Specifically, your market research provider should provide you with crystal clear answers to the following: Continue reading Does Your Stem Cell Market Intelligence Provider Use Futuristic Techniques?
This post considers six regions that have experienced unusual cord blood market activity or substantial change, often involving a shift in government policy surrounding cord blood banking. It is vital to understand market risks, as well as market opportunities, within different regions of the world, because trends in one area can often impact neighboring regions, or on a larger scale, can create global shifts within the cord blood industry.
Continue reading Geographical Differences in Cord Blood Banking: 6 Regions with Unusual Market Activity